Practical Radiation Oncology Program 2024

This program is designed to address the needs of a community practice physician and includes disease site reviews, interactive case-based discussions, a business fundamentals review and a radiopharmaceuticals overview.

Target Audience

The activity is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, nurses, radiation dosimetrists, physicists, pathologists, residents, neurosurgeons, diagnostic radiologists, radiation therapists, practice managers, dietitians and urologists.

Learning Objectives

Upon completion of this activity, participants should be able to do the following:

  • Discuss treatment options for patients with early stage breast cancer and those treated with neoadjuvant chemotherapy.
  • Discuss indications and treatment techniques for IMRT in breast cancer patients. 
  • Develop a framework for selecting the optimal treatment for patients with brain metastases.
  • Increase the tools for diagnosis and management of radionecrosis.
  • Best counsel patients on risk of neurotoxicity and options for mitigating and managing the toxicity. 
  • Describe the necessary components of maintaining a clinical practice.
  • Create a business plan advocating for a new technology or treatment.
  • Partner with clinic, hospital and organizational leaders to promote best practices in radiation oncology. 
  • Have evidence basis and comfort in treating osteoarthritis and plantar fasciitis with LD-RT.
  • Have evidence basis and comfort in treating other musculoskeletal/connective tissue disorders such as Dupuytren's and Lederhosen's.
  • Have understanding of potential treatments for tremors, dementia, depression.  
  • Describe three different intentions of radiotherapy: curative, disease-modifying and palliative radiotherapy.
  • List the essential components of having time-sensitive, meaningful conversations with patients and families about goals and values that can influence radiotherapy decision making. 
  • Determine the appropriate dose constraints to be utilized in common clinical situations including SBRT to central and peripheral lung lesions.
  • Assess common side effects of lung treatment and determine appropriate management. 
  • Describe the molecular pathologic features that should be included in pathology report for endometrial, vulvar and cervix cancers. 
  • Be able to discuss how pathologic factors, such as molecular status, influence prognosis and treatment decisions. 
  • Discuss recent clinical trial data for the management of gynecologic cancers and define what patient populations show survival benefits with these new approaches, such as immunotherapy. 
  • Be aware of the motivation and evidence for treating suitable prostate patients with SBRT. 
  • Feel confident in contouring, treatment planning and delivery of prostate SBRT. Be cognizant of tips to reducing side effects. 
  • Be familiar with approaches to building a successful community prostate SBRT program including advice on successful team building, marketing and reimbursement. 
  • Explain planning techniques to prevent treatment related side effects from head and neck cancer radiation. 
  • Describe management techniques to treat acute and late side effects from radiation to the head and neck. 
  • Identify indications for radiopharmaceuticals for prostate cancer.
  • Identify resources needed to implement radiopharmaceuticals in a community clinic.   
Course summary
Available credit: 
  • 12.50 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 12.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 12.50 Certificate of Attendance
    This activity was designated for 12.50 AMA PRA Category 1 Credit™.
Course opens: 
12/02/2024
Course expires: 
12/31/2025
Cost:
$699.00
Rating: 
0

The program is comprised of ten sessions: 

  1. Advances in Breast Cancer Management: Early-Stage Disease, Post-Neoadjuvant Radiation Therapy and IMRT for Breast Cancer Treatment
    • To Treat or Not To Treat: Patients with Early Stage Breast Cancer - Janice Lyons, MD
    • Radiation Therapy for Breast Cancer Patients Treated with Neoadjuvant Chemotherapy - Lisa Singer, MD, PhD
    • Indications and Techniques for Breast IMRT - Laura Warren, MD
  2. Brain Metastases Radiotherapy while Mitigating Radionecrosis and Neurotoxicity
    • Tailored Approach to Brain Metastases Management - Stuart Burri, MD
    • Mitigating and Managing Neurotoxicity from Radiotherapy for Brain Metastases - William Breen, MD
    • Prevention and Management Strategies for Radionecrosis - Raj Singh, MD
  3. Business of Radiation Oncology for Clinicians
    • Running a Private Practice - Christopher Jahraus, MD
    • How to Be a Partner with Your Business Manager - Curtiland Deville, MD, FASTRO
    • How to Build a Business Plan - Becki Swanson, OCN, BSN, RN, MSHA
    • What Academicians Need to Know About the Business of Radiation Oncology - Kimberly Smith, MPA
  4. Benign Radiotherapy: Back to the Future
    • LDRT for Osteoarthritis and Plantar Fasciitis - Nagendra (Bobby) Koneru, MD, FASTRO
    • Pain, Pain, Go Away...LD-RT in Dupuytrens Contracture and Other Musculoskeletal Disorders - Mudit Chowdhary, MD
    • Benign CNS: Opportunities and State of the Art - Jona Hattangadi-Gluth, MD, FASTRO
  5. Patient Guided Radiotherapy: Tools to Help Providers Support Patients when the "Right Choice" Isn't Always Clear
    • Goals of Care Conversations for the Radiation Oncologist - Emily Martin, MD
    • Defining Radiotherapy Intent - Joshua Jones, MD
  6. Prevention and Management of Toxicity in Organs at Risk (OAR)
    • Lung OAR: Conventional Fractionated Treatment - Julianna Bronk, MD, PhD
    • Lung OAR: Central and Ultracentral SBRT - Matthew Ning, MD, MPH
    • Lung OAR: Peripheral Lung SBRT - Shane Mesko, MD, MBA
  7. Gynecologic Tumor Board - Case-Based Discussion of the Molecular and Treatment Approach Updates for the Management of Endometrial, Vulvar and Cervical Cancers
    • Gynecologic Molecular Pathology Review for Endometrial, Vulvar and Cervix Cancers - Taylor Jenkins, MD
    • Endometrial Cancer Staging and Treatment Updates - The Significance of Pathology and Molecular Status - Susan Gueble, MD, PhD
    • Vulvar and Cervical Cancer Treatment Updates - Junzo Chino, MD, FASTRO
  8. Implementation of a Prostate SBRT Program in the Community Setting
    • Evidence that SBRT is a New Standard of Care for Localized Prostate Cancer - Nicholas van As, MD, MB
    • Building a Successful Community Prostate SBRT Practice - Jonathan Haas, MD
    • How to Safely Deliver Prostate SBRT in a Community Setting - Michael Zelefsky, MD, FASTRO 
  9. Head and Neck Cancer - Prevention and Management of Radiation Therapy Toxicity
    • Reduction in Head and Neck Cancer Toxicity: Simulation and Planning Considerations - Shauna Campbell, MD, DO
    • Management of Acute Toxicity from Head and Neck Radiation Therapy - Carryn Anderson, MD, FASTRO
    • Treatment of Late Toxicity from Head and Neck Radiation Therapy - Darrion Mitchell, MD, PhD 
  10. Introduction to Theranostics for the Community Radiation Oncologist
    • Radiopharmaceuticals for Prostate Cancer - Jeff Michalski, MD, MBA, FASTRO
    • Delivering Radiopharmaceuticals within a Radiation Oncology Clinic - Youssef Charara, PhD
    • Implementing a Multidisciplinary Theranostics Program in a Community Setting - Brandon Mancini, MD, MBA  

This activity is available from December 2, 2024, through 11:59 p.m. Eastern time on December 31, 2025.

This activity was originally recorded at the 2024 ASTRO Annual Meeting.

Faculty:

A list of all meeting faculty and Individual presenter disclosures are in the 2024 ASTRO Annual Meeting Faculty and Presenters' Disclosure or Relationships. All relevant financial relationships have been mitigated.

Planners:

The ASTRO Education Committee and the 2024 ASTRO Annual Meeting Education and Steering Committees had control over the content of this activity.

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.

Available Credit

  • 12.50 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 12.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 12.50 Certificate of Attendance
    This activity was designated for 12.50 AMA PRA Category 1 Credit™.
 
Status
Price
Title
$699.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.

Price

Cost:
$699.00
Please login or register to take this course.

Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.

Nonmember: $699
Member: $599
Postdoctoral Fellow Member: $299
Member-in-Training: $299
Student/Grad Student/PGY-1 Member: $299

If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.

Policies:
No refunds, extensions, or substitutions will be made for those registrants. Including those who for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.

Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement

The course and its materials will only be available on the ASTRO website until December 31, 2025 regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.